Rare diseases
Investigational molecules
Locations
Back to Portugal22 clinical trials in Torres Vedras, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type
PortugalStudy on the Effects of Semaglutide in Patients with Early Alzheimer's Disease
PortugalStudy on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer's Dementia Patients
PortugalStudy on the Effects of TAK-341 for Patients with Multiple System Atrophy
PortugalStudy of FNP-223 tablets to slow disease progression in patients with Progressive Supranuclear Palsy (PSP)
PortugalStudy on the Effectiveness and Safety of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis
PortugalStudy on the Effectiveness and Safety of ND0612 Infusion vs. Oral Treatment for Parkinson's Disease Patients with Motor Fluctuations
PortugalStudy on the Safety and Efficacy of Tominersen for Patients with Prodromal and Early Manifest Huntington's Disease
PortugalStudy on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant
PortugalStudy on the Safety and Effects of ABBV-916 and MK-6240 for Patients with Early Alzheimer's Disease
PortugalThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Alzheimer's disease and its associated conditions, including studies evaluating new treatments for psychosis and agitation in patients. Multiple trials are investigating cognitive decline interventions and novel therapeutic approaches.
Current studies are examining both oral medications and innovative therapeutic compounds.
Comprehensive research into Parkinson's disease and related movement disorders, including studies of new treatment delivery methods and genetic variants. Clinical trials are evaluating both symptomatic treatments and disease-modifying approaches.
Investigations focus on both traditional and innovative therapeutic approaches.
Pioneering research into rare conditions including Huntington's Disease, Progressive Supranuclear Palsy, and Multiple System Atrophy. Studies are evaluating novel compounds aimed at slowing disease progression.
These trials represent significant advances in rare disease research.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
